In This Article:
The Indian market has shown impressive performance, rising 1.0% in the last 7 days and up 45% over the past year, with earnings expected to grow by 17% annually in the coming years. In this robust environment, identifying small-cap stocks with strong potential can offer significant opportunities for investors seeking to capitalize on emerging growth stories.
Top 10 Undiscovered Gems With Strong Fundamentals In India
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
3B Blackbio Dx | 0.38% | -0.26% | -1.39% | ★★★★★★ |
Indo Amines | 82.32% | 17.15% | 20.00% | ★★★★★☆ |
Om Infra | 13.99% | 43.36% | 27.64% | ★★★★★☆ |
Voith Paper Fabrics India | 0.07% | 10.95% | 9.70% | ★★★★★☆ |
Gallantt Ispat | 18.85% | 37.56% | 37.26% | ★★★★★☆ |
Master Trust | 37.05% | 27.57% | 41.99% | ★★★★★☆ |
Nibe | 39.26% | 80.75% | 84.68% | ★★★★★☆ |
Lotus Chocolate | 13.51% | 28.07% | -10.66% | ★★★★★☆ |
Magadh Sugar & Energy | 85.44% | 6.65% | 13.60% | ★★★★☆☆ |
Monarch Networth Capital | 32.66% | 30.99% | 50.24% | ★★★★☆☆ |
We're going to check out a few of the best picks from our screener tool.
Aarti Pharmalabs
Simply Wall St Value Rating: ★★★★★☆
Overview: Aarti Pharmalabs Limited, along with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally, with a market cap of ₹62.40 billion.
Operations: Aarti Pharmalabs generates revenue primarily from its pharmaceuticals segment, amounting to ₹19.50 billion.
Aarti Pharmalabs, a noteworthy player in the Indian pharmaceuticals sector, has shown impressive financial performance with earnings growth of 19.4% over the past year, surpassing industry growth. The company’s net debt to equity ratio stands at a satisfactory 10.9%, and its interest payments are well covered by EBIT at 21.7x coverage. Recent board appointments bring extensive industry experience, and Q1 2025 results reported revenue of ₹5.58 billion (up from ₹4.59 billion).
-
Click to explore a detailed breakdown of our findings in Aarti Pharmalabs' health report.
-
Gain insights into Aarti Pharmalabs' past trends and performance with our Past report.
Netweb Technologies India
Simply Wall St Value Rating: ★★★★★★
Overview: Netweb Technologies India Limited designs, manufactures, and sells high-end computing solutions (HCS) in India with a market cap of approximately ₹153.40 billion.
Operations: Netweb Technologies India Limited generates revenue primarily through the manufacturing and sale of computer servers, amounting to ₹8.14 billion. The company's market cap is approximately ₹153.40 billion.